Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose?
- PMID: 25486625
- PMCID: PMC4385393
- DOI: 10.1016/j.jpain.2014.11.007
Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose?
Abstract
Current research on the risk of opioid analgesics with drug overdose does not account for the total morphine equivalent dose (MED) of opioids filled by a patient. In this study, time from first opioid prescription until drug overdose was examined for 206,869 privately insured patients aged 18 to 64 with noncancer pain and ≥2 filled prescriptions for Schedule II or III opioids from January 2009 to July 2012. Opioid therapy was examined in 6-month intervals including 6 months before an overdose and categorized as mean daily MED (0, 1-19, 20-49, 50-99, ≥100 mg) and total MED divided at top quartile (0, 1-1,830, >1,830 mg). Survival analysis was used, adjusting for demographics, clinical conditions, and psychoactive drugs. Relative to no opioid therapy, persons at highest risk for overdose (adjusted hazard ratios of 2-3) received a daily MED of ≥100 mg regardless of total dose or a daily MED of 50 to 99 mg with a high total MED (>1,830 mg). The hazard ratio was significantly lower (1.43, 95% confidence interval = 1.15-1.79) for 50 to 99 mg daily MED with a lower total MED (≤1,830 mg), whereas hazard ratios for lower daily MEDs did not differ by total dose. This analysis suggests that clinicians should consider total MED to assess risk of overdose for persons prescribed 50 to 99 mg daily MED.
Perspective: When addressing risks for drug overdose, this analysis supports the need for clinicians, administrators, and policy makers to monitor not only daily opioid dose but also total dose for patients receiving 50 to 99 mg daily MED.
Keywords: Analgesics; chronic pain; dose response relationship; drug; opioid; overdose.
Published by Elsevier Inc.
Conflict of interest statement
None of the authors have any conflicts of interest or disclosures to report that purposefully or inadvertently affect the conduct, outcome, or reporting of any scholarly activity.
Figures
![None](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4385393/bin/nihms670814f1.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4385393/bin/nihms670814f2.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4385393/bin/nihms670814f3.gif)
Similar articles
-
Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.PLoS Med. 2019 Nov 5;16(11):e1002941. doi: 10.1371/journal.pmed.1002941. eCollection 2019 Nov. PLoS Med. 2019. PMID: 31689302 Free PMC article.
-
Opioid prescriptions for chronic pain and overdose: a cohort study.Ann Intern Med. 2010 Jan 19;152(2):85-92. doi: 10.7326/0003-4819-152-2-201001190-00006. Ann Intern Med. 2010. PMID: 20083827 Free PMC article.
-
Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders.J Gen Intern Med. 2015 Aug;30(8):1081-96. doi: 10.1007/s11606-015-3199-4. Epub 2015 Feb 4. J Gen Intern Med. 2015. PMID: 25650263 Free PMC article.
-
Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.JAMA Intern Med. 2015 Apr;175(4):608-15. doi: 10.1001/jamainternmed.2014.8071. JAMA Intern Med. 2015. PMID: 25686208
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
-
Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies.CMAJ. 2023 Oct 23;195(41):E1399-E1411. doi: 10.1503/cmaj.230459. CMAJ. 2023. PMID: 37871953 Free PMC article.
-
Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain.BMC Musculoskelet Disord. 2023 May 30;24(1):432. doi: 10.1186/s12891-023-06537-0. BMC Musculoskelet Disord. 2023. PMID: 37254090 Free PMC article. Review.
-
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors.Int J Clin Pharm. 2022 Apr;44(2):428-438. doi: 10.1007/s11096-021-01360-w. Epub 2021 Dec 2. Int J Clin Pharm. 2022. PMID: 34855069 Free PMC article.
-
Opioid use in patients with peripheral arterial disease undergoing lower extremity bypass.J Vasc Surg. 2022 Mar;75(3):998-1007. doi: 10.1016/j.jvs.2021.08.104. Epub 2021 Oct 1. J Vasc Surg. 2022. PMID: 34606956 Free PMC article.
-
Opioid prescription patterns among urologists as compiled from within Medicare.Can Urol Assoc J. 2021 Nov;15(11):E574-E581. doi: 10.5489/cuaj.7086. Can Urol Assoc J. 2021. PMID: 33999804 Free PMC article.
References
-
- Agency Medical Director's Group. Web-Base Opioid Dose Calculator. [Accessed April 7, 2014]; Available at: http://agencymeddirectors.wa.gov/mobile.html.
-
- Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321. - PubMed
-
- Centers for Disease Control and Prevention: National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. [Accessed April 10, 2014]; Available at: http://www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.html. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources